A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the ...

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the two key pathological hallmarks of Alzheimer's—tau protein and beta-amyloid ...

There is no cure. Between 1995 and 2021, around $42bn was poured into more than 1,000 clinical trials. Yet only a handful of ...

Alzheimer’s is a mind-body malaise that experts say can take up to 20 years to run its fearsome course—like having a sliver ...

II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

The finding may open a whole new world in the study of Alzheimer's disease, said biophysicist Aneta Stefanovska.

Billions of dollars have been spent on Alzheimer’s research over many decades, yet no effective treatment exists. Investigative journalist Charles Piller has revealed one reason for the impasse: ...

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

The exact cause of Alzheimer's disease hasn't been identified. The current thinking is that it develops due to a combination of genetic, lifestyle, and environmental risk factors.1 The brains of ...

Evidence indicates that smoking tobacco may have links to Alzheimer’s disease, but nicotine on its own could temporarily help memory and cognitive function. However, more research is still ...